Keyphrases
Adjuvant Therapy
16%
Advanced Solid Tumors
16%
Circulating Tumor DNA (ctDNA)
100%
Clinical Decisions
16%
Clinical Implementation
33%
Clinical Utility
16%
Commercial Platform
16%
Curative Intent Treatment
16%
Development Implementation
16%
Diagnostic Test
16%
Disease Relapse
16%
Disease Response
16%
DNA Sequencing
16%
Effective Implementation
16%
Genetic Modification
16%
High-throughput Detection
16%
Liquid Biopsy
83%
Metastatic Disease
16%
Minimal Residual Disease
100%
Neoadjuvant Therapy
16%
Ongoing Trials
16%
Patients with Cancer
16%
Predicting Diseases
16%
Solid Tumors
100%
Technological Characteristics
16%
Tumor
16%
Medicine and Dentistry
Adjuvant Therapy
20%
Chloroplast DNA
100%
Circulating Tumor DNA
100%
Diagnostic Test
20%
Diseases
40%
Liquid Biopsy
100%
Minimal Residual Disease
100%
Neoadjuvant Therapy
20%
Neoplasm
20%
Sensitive Detection
20%
Solid Malignant Neoplasm
100%